InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,468.88
(
-0.01%
)
US TECH 100
19,226.80
(
0.27%
)
Dow Jones
39,164.72
(
0.13%
)
Brent Oil
84.43
(
0.29%
)
Bitcoin
61,462.81
(
-0.56%
)
Post# of 2795
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12467
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: DewDiligence post# 2543

Tuesday, 05/09/2017 8:35:47 PM

Tuesday, May 09, 2017 8:35:47 PM

Post# of 2795

I think OCRX has a fair—but not great—chance of persuading the FDA to endorse advancing OCR-002 to phase-3,



I agree and that is why I exited my position on the pop a month ago on the STOP-HE data update. Fair chance doesn't cut it anymore for me..

Buyout might be possible..
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up